WeVote
Log In

Bill

Bill

HR 4661

Encourages screening and treatment for kidney disease

2026 Regular Session Introduced by George Hruza and 1 co-sponsor

Missouri bill encourages kidney disease screening and treatment programs to improve early detection and patient outcomes through public health initiatives.

Reported Do Pass (H) - AYES: 9 NOES: 0 PRESENT: 0
0
WeVote Research Nonpartisan
Bill Summary · HR 4661

Legislative bill overview

HR 4661 encourages screening and treatment programs for kidney disease in Missouri, likely through public health initiatives, healthcare provider education, or patient awareness campaigns. The bill was recently introduced in the Missouri House and is in early stages of the legislative process. Specific mechanisms for implementation and funding are not detailed in the available information.

Why is this important

Kidney disease affects millions of Americans and often goes undiagnosed until advanced stages, resulting in higher healthcare costs and worse patient outcomes. Early detection through screening can significantly improve treatment effectiveness and quality of life. Public health initiatives addressing kidney disease represent a preventive approach that could reduce burden on dialysis services and transplant programs.

Potential points of contention

  • Funding source: Whether the state will allocate new budget funds or require healthcare providers to absorb screening costs
  • Scope of screening: Disagreement over which populations should be screened (universal vs. risk-based) and at what frequency
  • Implementation burden: Concerns from healthcare providers about administrative requirements and workflow disruption

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.